Wyden, Brown urge FTC to investigate PBM 'co-manufacturing' arrangements
FierceHealthIT
OCTOBER 1, 2024
Two key senators are urging the Federal Trade Commission to investigate "co-manufacturing" arrangements that they fear pharmacy benefit managers may be using to stymie competition. | Two key senators are urging the Federal Trade Commission to investigate "co-manufacturing" arrangements that they fear pharmacy benefit managers may be using to stymie competition.
Let's personalize your content